JAK2 and COVID-19: It also inhibits JAK2 with a lower potency.226–228 Several studies indicated that it suppresses S-protein-potentiated STAT1 signaling and combats lung tissue-resident memory T cells which cause chronic inflammation and fibrosis when treating COVID-19.210,229,230